INTRODUCTION
============

Inflammatory bowel disease (IBD) mainly comprised of ulcerative colitis (UC) and Crohn's disease (CD) is characterized by chronic inflammation of the gastrointestinal tract with multi-factorial ethiology.[@b1-jcp-20-260] When a patient presents with symptoms such as diarrhea, abdominal pain, hematochezia, and weight loss,[@b2-jcp-20-260] then they suggestive UC or CD. For research of IBD, there are several kinds of animal models of colonic inflammation.[@b3-jcp-20-260] Generally, IBD colitis models are classified into five groups: chemically induced model, spontaneous model, cell-transfer model, congenital model, and genetically engineered model.[@b3-jcp-20-260] Among various mice colitis models, dextran sodium sulfate (DSS)-induced colitis is widely used because of its simplicity, time- and cost-saving.[@b3-jcp-20-260],[@b4-jcp-20-260] First report of DSS-induced colitis model was published in the year 1985, by Ohkusa,[@b5-jcp-20-260] which has some advantages in comparison with other animal models of colitis. For example, administration of DSS in drinking water provokes acute or chronic colitis depending on the administration concentration.[@b6-jcp-20-260] Moreover, severe DSS-induced colitis closely resembles the clinical features of human UC.[@b7-jcp-20-260] However, as there are several DSS-induced mice model protocols depending on concentration of DSS or ages of mice,[@b8-jcp-20-260],[@b9-jcp-20-260] the beginners experience difficulty in the choosing the effective condition. From this background the aim of this research was to investigate the proper model for acute IBD study by combinations of DSS concentration and ages in C57BL/6 mice. In addition, we tried to find the effective measurement method of IBD induction among colon length, body weight, diarrhea, hematochezia, histological finding, and interleukin 1 beta (IL-1β).

MATERIALS AND METHODS
=====================

1.. Animals and dextran sodium sulfate
--------------------------------------

Five or nine-week-old C57BL/6 male mice (Orient Co. Ltd., Seoul, Korea) were used for the experiments. All mice were housed in a cage maintained at 23°C with a 12/12-hour light/dark cycle under specific pathogen-free conditions. Control and 2.5% DSS group was administered to six male C57BL/6 mice and 4% DSS was administered to eight mice. At first day, both control group and DSS group were administered orogastrically with vehicle only. And DSS (MP Biomedicals, Santa Ana, CA, USA; M.W 36--50 kDa, Ref = 160110) group were administered with DSS vehicle from 2 to 7 days. Both control and DSS group were sacrificed by CO2 asphyxiation at 7 days. The time schedule of this study is represented in [Figure 1](#f1-jcp-20-260){ref-type="fig"}. From the day of experiment administration, all mice were labeled and the weights of mice were measured daily. Features of stool, such as diarrhea or bloody stool, from each mouse were observed every day. All experimental procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of Seoul National University Bundang Hospital (IACUC number: BA1506-178-039-01).

2.. Body weight, diarrhea, hematochezia and colon lengths
---------------------------------------------------------

Severity and inflammation of colitis were assessed by examining body weight, diarrhea, hematochezia and colon length. The body weights of all mice were measured from the date of administration to sacrifice daily. All mice were observed for stool consistency and rectal bleeding every day. To assess the severity of colitis, disease activity index (DAI) score were monitored daily.[@b10-jcp-20-260] The colon length was measured at sacrifice time which was performed on Day 7 of experiment.

3.. Measurement of interleukin 1 beta
-------------------------------------

Increased pro-inflammatory cytokine is a hallmark of DSS-induced colitis. Therefore, the level of IL-1β in the colon was measured by ELISA assay. Ten milligrams of colon strip (one from the ascending colon \[AC\] and one from the descending colon \[DC\]) was homogenized for 30 seconds with a polytron homogenizer in 200 μL of ice-cold lysis buffer (200 mM NaCl, 5 mM EDTA, 10 mM Tris \[pH 7.4\], 10 % glycerin, 1 mM phenylmethylsulfonyl fluoride, 1 μg/mL leupeptin and 28 μg/mL aprotinin). Suspensions were centrifuged at 13,000 rpm for 15 minutes and the resulting supernatant was assayed using an IL-1 ELISA kit (R&D Systems, Minneapolis, MN, USA) according to the manufacturer's instruction. Protein concentration was measured by using Bio-Rad protein assay kit (Bio-Rad laboratories, Hercules, MA,USA).

4.. Histopathological analysis
------------------------------

Proximal and distal colonic sections were fixed in 10% formalin and embedded in paraffin. The 5-mm sections were stained with haematoxylin and eosin (H&E). The microscopic colonic epithelial damage was assigned scores as follows: 0 = normal; 1 = hyperproliferation, irregular crypts, and goblet cell loss; 2 = mild to moderate crypt loss (10%--50%); 3 = severe crypt loss (50%--90%); 4 = complete crypt loss, surface epithelium intact; 5 = small- to medium-sized ulcer (\< 10 crypt widths); and 6 = large ulcer (≥ 10 crypt widths). Infiltration with inflammatory cells was assigned scores separately for mucosa (0 = normal, 1 = mild, 2 = modest, 3 = severe), submucosa (0 = normal, 1 = mild to modest, 2 = severe), and muscle/serosa (0 = normal, 1 = moderate to severe). Scores for epithelial damage and inflammatory cell infiltration depending on colonic depth were added, resulting in a total scoring range of 0 to 12.[@b11-jcp-20-260]

5.. Statistical analysis
------------------------

Data are expressed as mean ± SEM. Comparison of between the 3 groups (2.5% DSS, 4% DSS and control) was performed using the Kruskal-Wallis test. Comparison of between the 2 different groups was performed using the Mann-Whitney test. And Fisher's exact test was used for categorical data. *P*-values less than 0.05 were considered statistically significant. All statistical analyses were performed using IBM SPSS software ver. 22.0 (IBM Co., Armonk, NY, USA).

RESULTS
=======

1.. Body weight, diarrhea and hematochezia
------------------------------------------

The body weights of all mice of control and DSS group was measured daily. The change of body weight from D0 to D7 express is shown at [Figure 2A](#f2-jcp-20-260){ref-type="fig"}. The baseline of the weight change was the mean weight of first day (D0). The weight loss was definitely observed from Day 5 in DSS group in both 2.5% and 4% DSS group ([Fig. 2A](#f2-jcp-20-260){ref-type="fig"}). Hematochezia was more frequent in 4% DSS group than 2.5% DSS group ([Fig. 2B](#f2-jcp-20-260){ref-type="fig"}). At sacrifice day, the ratio of hematochezia of 4% DSS mice in nine-week was significantly higher than that of 2.5% DSS mice in five-week (87.5% vs. 62.5%), but it did not reach statistical significance (*P* = 0.569).

2.. Disease activity index score
--------------------------------

To evaluate the severity of colitis, DAI score were monitored daily. The DAI score was determined based on the methods of Friedman et al.[@b10-jcp-20-260] The DAI score was calculated as the sum of the weight loss score, the diarrheal score and the hematochezia score ([Table 1](#t1-jcp-20-260){ref-type="table"}) and the result of daily DAI score was represented at [Table 2](#t2-jcp-20-260){ref-type="table"}. The DAI score of both control group in five- and nine-week was 0 in all experiment day ([Table 2](#t2-jcp-20-260){ref-type="table"}). In 5-week 2.5% DSS group, DAI score began to increase from 2 day of administration and that of nine-week 4% DSS mice markedly increased from 4 day of administration ([Table 2](#t2-jcp-20-260){ref-type="table"}). DAI score of both 2.5% and 4% DSS group was statistically higher than that of each control group (*P* \< 0.05) ([Fig. 2C](#f2-jcp-20-260){ref-type="fig"}). In terms of age at 4% DSS group DAI score at nine-week showed higher score in comparison of that at five-week from DSS 3 day to DSS 6 day (*P* = 0.012--0.047) ([Fig. 2C](#f2-jcp-20-260){ref-type="fig"}). However, at five-week mice only one day (DSS 2 day) of 4 % DSS group showed statistical significance in comparison to 2.5% DSS group (*P* = 0.044).

3.. Colon lengths
-----------------

The colon lengths of all mice were measured at sacrifice day 7. The mean colon length of DSS group was significantly shorter than that of control group in both five- and nine-week mice ([Fig. 3A](#f3-jcp-20-260){ref-type="fig"}). The colon lengths of 2.5% DSS in five-week was slightly shorter than that of nine-week mice, but the results were not statistically significant (*P* = 0.871) ([Fig. 3A](#f3-jcp-20-260){ref-type="fig"}). In addition, there was no statistical significance between 2.5% and 4% DSS mice in nine-week (6.4 ± 0.35 vs. 6.83 ± 0.82, *P* = 0.362).

4.. Production of interleukin 1 beta
------------------------------------

At five-week DSS group, the level of IL-1β (pg/mg) expression of colonic mucosa was much higher than that of control group (control, 43.8 ± 6.8; 2.5% DSS, 675.3 ± 52.9; 4% DSS, 732.0 ± 138.3). Similarly, in nine-week DSS mice group, the level of IL-1β (pg/mg) in the colonic mucosa was also much higher than control group (control, 35.2 ± 7.3; 2.5% DSS, 625.9 ± 43.0; 4% DSS, 753.4 ± 101.1) ([Fig. 3B](#f3-jcp-20-260){ref-type="fig"}). There was a great difference of IL-1β level between control and DSS group (*P* \< 0.05). However, there was no significant difference of IL-1β level between 2.5% and 4% DSS group or between five- and nine-week ([Fig. 3B](#f3-jcp-20-260){ref-type="fig"}).

5.. Histopathological analysis
------------------------------

No damage was observed histologically in the colon mucosa of control group mice in 5- and 9-week in the AC and DC ([Fig. 4A∼4D](#f4-jcp-20-260){ref-type="fig"}). The crypts were straight and the base of the tubular glands reached the muscularis mucosa. The epithelial cell layer on the surface of the mucosa was intact ([Fig. 4A∼4D](#f4-jcp-20-260){ref-type="fig"}). In contrast, DSS groups showed destruction of crypts and infiltration of inflammatory cell, which were more frequently observed in DC ([Fig. 4F, 4H, 4J, and 4L](#f4-jcp-20-260){ref-type="fig"}) than in AC ([Fig. 4E, 4G, 4I, and 4K](#f4-jcp-20-260){ref-type="fig"}). The microscopic findings of AC showed partial crypt distortion and infiltration of inflammatory cells. Nearly complete crypt destruction and marked infiltration of inflammatory cells were observed in DC ([Fig. 4F, 4H, 4J, and 4L](#f4-jcp-20-260){ref-type="fig"}). However, ulcer of colonic mucosa was rarely observed in colonic mucosal of DSS group.

When the microscopic histological damage score was calculated based on microscopic colonic epithelial damage and infiltration of inflammatory cell the score of DC was higher than that of AC ([Fig. 5](#f5-jcp-20-260){ref-type="fig"}). The microscopic damage score had statistical significance in DC of DSS mice than AC in 4% DSS group of five-week (AC of 4% DSS, 5.17 ± 0.31; DC of 4% DSS, 6.67 ± 0.42; *P* = 0.026) ([Fig. 5](#f5-jcp-20-260){ref-type="fig"}). The microscopic damage score had statistical significance in DC of DSS mice than AC in 4% DSS group of nine-week (AC of 4% DSS, 5.50 ± 0.49; DC of 4% DSS, 6.63 ± 0.33; *P* = 0.043) ([Fig. 5](#f5-jcp-20-260){ref-type="fig"}). However, there was no statistical significance of the microscopic damage score between DSS concentration or age of mice.

DISCUSSION
==========

IBD is comprised of two major disorders, UC and CD of which epidemiology has been published in various countries. The recent systemic research shows that the highest incidence area of IBD are Europe and North America and the low incidence area are Asia and the Middle East.[@b12-jcp-20-260] In South Korea, a population-based study showed that the prevalence rates of UC and CD has rapidly increased for 20-year.[@b13-jcp-20-260] IBD decreases quality of life due to low remission rate and frequent recurrences. In addition, it also increases the risk of colorectal cancer, which is related to the anatomic extent and duration of the disease.[@b14-jcp-20-260] Actually, the colorectal cancer in the patients of IBD showed poor prognosis than sporadic colorectal cancer.[@b15-jcp-20-260] Thus, well treatment of IBD improves the quality of life and prevents the development of colorectal cancer.

Treatment options for IBD, such as 5-aminosalicylic acid, corticosteroids, antibiotics, immunosuppressive agents (e.g., tacrolimus) and biologics (e.g., infliximab) are selectively used depending on the severity and location of the disease and the tolerability of side effects.[@b16-jcp-20-260],[@b17-jcp-20-260] Many different kinds of animal models have been established to study IBD.[@b3-jcp-20-260] Especially, selection of effective animal model is very important to develop new IBD medicine. In the present study, we used DSS because of its simplicity, low coast and short time to make acute IBD mice model. Administration of DSS in drinking water induces acute mucosal injury characterized by diarrhea, body weight loss, hematochezia, and shortening of colon length. This symptom would be induced by direct hyperosmotic injury to epithelial cells.[@b18-jcp-20-260] In addition, weight loss of DSS mice is the evidence of inflammation compared to the control group.[@b9-jcp-20-260] However, this inflammatory reaction could be different depending on concentration of DSS. As the usual concentration of DSS was found to be 2.5% or 4% we decided to compare two concentrations in the present experiment. In the next mice age for DSS model should be decided before effective experiment. For example the inflammatory reaction of small bowel to NSAID was very different depending on age in the rat.[@b19-jcp-20-260] Actually, several research articles used mice with variable age for DSS-induced acute colitis model.[@b9-jcp-20-260],[@b20-jcp-20-260],[@b21-jcp-20-260] In the present study, all DSS mice had sign of acute inflammatory colitis than control group, and the colon length was significantly changed in all DSS mice in the present study. However, it was very difficult to choose adequate conditions such as age (5 or 9 weeks) and concentration of DSS (2.5% or 4%) by one measurement tool because there was no significant difference in the body weight, diarrhea, hematochezia, colon length, microscopic pathology, and the level of IL-1β of mice colon. Instead, when DAI score was applied which is calculated by combination of weight loss, diarrhea and hematochezia, 4% DSS group in nine-week was found to be adequate IBD mice model than any other combinations. Therefore, nine-week 4% DSS mice was an adequate DSS-induced colitis as an IBD model when assessed by DAI. In addition, this results confirms that DAI score is very important and effective tool in the selection of conditions for the IBD mice model.

IL-1β is an inflammatory cytokine produced predominantly by activated macrophages and monocytes,[@b22-jcp-20-260] and its increased production has been revealed at both the mRNA and protein levels in human IBD.[@b23-jcp-20-260] The enhanced production of IL-1β has been reported in DSS-induced colitis models.[@b24-jcp-20-260],[@b25-jcp-20-260] In addition, it is regarded as a critical cytokine in the pathogenesis of the murine colitis.[@b26-jcp-20-260] In the present study, IL-1β level in the DSS group was much higher than control group, but IL-1β did not show a statistical difference among different ages of mice or concentration of DSS. Thus our results suggest that DAI is more useful indicator than IL-1β level in the selection of effective DSS-induced mice IBD model.

As the grading of colonic inflammation by histology is rather difficult and expensive it is very important to select the proper site of inflammation There has been a report that histopathological damage was more commonly observed in DC than in AC.[@b27-jcp-20-260] However, other study described that inflammation score of the middle colon was most higher than in the proximal or in the distal colon of mice.[@b28-jcp-20-260] However, as the length of mice colon is rather short we chose AC and DC instead of middle colon for histologic examination. In the present study, there was no definite ulcer in any conditions. In terms of site the microscopic damage score was higher in DC than in AC. However, when the severity of histologic inflammation was compared, there was no statistical significance among groups classified by concentration of DSS or age of mice. These results suggest that distal part of colonic mucosa would be more proper to evaluate epithelial damage and infiltration of inflammatory cell than proximal part of colonic mucosa. In addition, DAI score is more effective method than histology in the measurement of inflammation or drug response in the DSS-induced mice model.

In spite of several strong points our results also have some limitations. First, the sample size was rather small. Second, two conditions for the age of mice or concentration of DSS was performed based on literature. Actually, this study was a preparatory experiment before the measurement of drug response in the DSS-induced IBD model. Thus this study was focused to find out the simple conditions for DSS-induced mice model and to set up efficient measurement tool for the inflammation of DSS mice model.

In conclusion, our study demonstrated that 2.5% and 4% DSS induced significant inflammatory reaction in both 5- and 9-week mice. Among them, nine-week 4% DSS mice was found to be an optimal IBD model as assessed by DAI score though histological change, level of IL-1β didn't show significant changes depending on DSS concentrations or mice age. DAI score was useful indicator and descending colon was more appropriate site for histological evaluation of colitis than AC. Therefore, this study helps to establish the simple and clinically effective DSS-induced colitis in mice as a model of IBD.
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![Schematic diagram of study design. D, day of administration; DSS, dextran sodium sulfate.](jcp-20-260f1){#f1-jcp-20-260}

![(A) The change of body weight was represented by ratio from administration day of study. The change in body weight show statistical difference from five days in both five- and nine-week group. ^b^*P* \< 0.05 (5-week, control vs. 2.5% DSS), ^a^*P* \< 0.05 (5-week, control vs. 4% DSS). (B) The ratio of hematochezia in mice was represented. The highest ratio group was 4% DSS in nine-week, but there was no statistical difference compared to other DSS group. ^a^*P* \< 0.05 (control vs. 5-week), ^b^*P* \< 0.05 (control vs. 9-week). (C) Disease activity index (DAI score) are composed of the change of body weight, diarrhea, and hematochezia. The 4% DSS mice in nine week showed the highest DAI score, and there was statistical difference compared to 4% DSS mice in five-week. Data are presented as means ± SEMs. ^a^*P*\< 0.05 (control vs. 5-week), ^b^*P* \< 0.05 (control vs. 9-week), ^c^*P* \< 0.05 (5-week, 2.5% vs. 4% DSS), ^d^*P* \< 0.05 (4% DSS, 5-week vs. 9-week). D, day of administration; DSS, dextran sodium sulfate.](jcp-20-260f2){#f2-jcp-20-260}

![(A) The colon length of control and dextran sodium sulfate (DSS) group after sacrifice. The colon length of all DSS group was significantly short than that of control group. But there was no statistical difference between 2.5% and 4% DSS group. ^a^*P* \< 0.05 (control vs. 5-week), ^b^*P* \< 0.05 (control vs. 9-week). (B) The level of interleukin 1 beta (IL-1β) in the colonic mucosa was measured by reverse transcription-PCR. The level of IL-1 of all DSS group was significantly higher than that of control group. But there was no statistical difference between 2.5% and 4% DSS group. Data are presented as mean ± SEM. ^a^*P* \< 0.05 (control vs. 5-week), ^b^*P* \< 0.05 (control vs. 9-week).](jcp-20-260f3){#f3-jcp-20-260}

![Histopathologic findings of the colonic mucosa (H&E, × 200). Normal colonic mucosa of control group in five-week AC (A), DC (B); control group in nine-week AC (C), DC (D); infiltration of inflammatory cell and crypts loss (50%) at colonic mucosa of 2.5% DSS in five-week AC (E), marked infiltration of inflammatory cell and nearly total loss of crypts at colonic mucosa of 2.5% DSS in five-week DC (F); colonic mucosa of 2.5% DSS in nine-week AC (G), DC (H); colonic mucosa of 2.5% DSS in nine-week AC (I), nearly total crypts loss and infiltration of severe inflammatory cell of colonic mucosa and submucosa (arrow) (J); 4% DSS in nine-week AC (K), erosion and infiltration of lymphocyte (arrow) at DC (L). AC, ascending colon; DC, descending colon; DSS, dextran sodium sulfate.](jcp-20-260f4){#f4-jcp-20-260}

![Microscopic damage score. The damage score of DC are more higher that that of AC. The comparison of DC and AC of 4% DSS group in five- and nine-week showed statistical significance (*P*\< 0.05). Data are presented as mean ± SEM. ^a^*P* \< 0.05 (control vs DSS), ^b^*P* \< 0.05 (AC vs. DC). AC, ascending colon; DC, descending colon; DSS, dextran sodium sulfate.](jcp-20-260f5){#f5-jcp-20-260}

###### 

Scoring system of disease activity index[^a^](#tfn1-jcp-20-260){ref-type="table-fn"}

  Score   Weight loss (%)   Stool consistency                                         Hematochezia[^b^](#tfn2-jcp-20-260){ref-type="table-fn"}
  ------- ----------------- --------------------------------------------------------- ----------------------------------------------------------
  0       None              Normal                                                    Absence
  1       0--10                                                                       
  2       11--15            Loose stool[^c^](#tfn3-jcp-20-260){ref-type="table-fn"}   
  3       16--20                                                                      
  4       \>20              Diarrhea                                                  Presence

DAI = (score of weight loss) + (score of stool consistency) + (score of hematochezia).

The presence of gross blood in the stool or anus.

The formation of a stool that readily becomes paste on anus of mice.

###### 

Disease activity index score

  Week       Group     D0   D1                                                        D2                                                        D3                                                        D4                                                        D5                                                        D6
  ---------- --------- ---- --------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------- --------------------------------------------------------- ----
  5-week     Control   0    0                                                         0                                                         0                                                         0                                                         0                                                         0
  2.5% DSS   0         0    0.67 ± 0.21[^a^](#tfn5-jcp-20-260){ref-type="table-fn"}   0.17 ± 0.17                                               0.5 ± 0.34                                                2 ± 1.26                                                  4.83 ± 1.87                                               
  4% DSS     0         0    0.13 ± 0.13[^a^](#tfn5-jcp-20-260){ref-type="table-fn"}   0.25 ± 0.25[^b^](#tfn6-jcp-20-260){ref-type="table-fn"}   1 ± 0.76[^b^](#tfn6-jcp-20-260){ref-type="table-fn"}      3.38 ± 1.24[^b^](#tfn6-jcp-20-260){ref-type="table-fn"}   5.75 ± 1.41[^b^](#tfn6-jcp-20-260){ref-type="table-fn"}   
  9-week     Control   0    0                                                         0                                                         0                                                         0                                                         0                                                         0
  2.5% DSS   0         0    0.17 ± 0.17                                               0.5 ± 0.22                                                0.83 ± 0.48                                               2.83 ± 1.28                                               5.33 ± 1.8                                                
  4% DSS     0         0    0.38 ± 0.18                                               1.25 ± 0.25[^b^](#tfn6-jcp-20-260){ref-type="table-fn"}   4.13 ± 1.23[^b^](#tfn6-jcp-20-260){ref-type="table-fn"}   7 ± 1.04[^b^](#tfn6-jcp-20-260){ref-type="table-fn"}      8.38 ± 1.07[^b^](#tfn6-jcp-20-260){ref-type="table-fn"}   

Values are presented as mean only or mean ± SEM. D, day of administration; DSS, dextran sodium sulfate.

*P* \< 0.05 (5-week, 2.5% vs. 4% DSS).

*P* \< 0.05 (4% DSS, 5-week vs. 9-week).
